Masonic Medical Research Institute will host its first telethon Tuesday, Oct. 6, 2026, streaming live across the institute's ...

PRKAG2 syndrome is an autosomal dominant Atrium Therapeutics has received clearance from the US Food and Drug Administration ...

Atrium Therapeutics, Inc. (the "Company"), a biopharmaceutical company dedicated to delivering RNA therapeutics to the heart, announced today that the U.S. Food and Drug Administration (FDA) has ...

At the 2026 AVMA Convention, Will P. Rausch, DVM, DACVIM (Cardiology), discussed where NT-proBNP fits in feline cardiomyopathy screening and why the test should be used as part of a broader diagnostic ...

There is broad consensus on the benefits of aerobic exercise training in patients with cardiovascular disease to improve cardiorespiratory fitness and lower the risk of adverse cardiovascular events.

Background C-reactive protein (CRP) is commonly used to assess systemic inflammation, yet its prognostic value in acute ...

Objective Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiomyopathy characterised by pathological left ...

Heart disease is often associated with blocked arteries or heart attacks, but not all heart conditions develop the same way.

Saturnus Bio is a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet need The collaboration will ...

Merck KGaA, Darmstadt, Germany, Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies ...

A medication used to treat type 2 diabetes can significantly reduce the risk of heart failure in individuals who are genetically predisposed to cardiomyopathy, according to new research led by Harvard ...

Physical activity in children and teenagers with cardiomyopathy (conditions that affect the heart muscle's structure and function, impairing its ability to pump or fill effectively), as well as ...